Arthritis Is Chronic Condition Suitable For OTC Treatment, Suggests Schachtel
This article was originally published in The Tan Sheet
Executive Summary
Chronic conditions such as arthritis should be considered by FDA as viable OTC drug indications since many consumers already take nonprescription products for such off-label, non-acute uses, Bernard Schachtel, MD, Schachtel Research Centers, Inc., said at the Institute for International Research's Rx-to-OTC switch marketers forum in New York City Oct. 22-23.
You may also be interested in...
OTC Statin Target Population Receives Significant FDA Attention
The type of people most suited for OTC statin therapy received considerable attention from FDA during the agency's discussion on the OTC availability of vascular drugs at a public meeting in Gaithersburg, Md. June 28-29.
OTC Statin Target Population Receives Significant FDA Attention
The type of people most suited for OTC statin therapy received considerable attention from FDA during the agency's discussion on the OTC availability of vascular drugs at a public meeting in Gaithersburg, Md. June 28-29.
OTC Statin Target Population Receives Significant FDA Attention
The type of people most suited for OTC statin therapy received considerable attention from FDA during the agency's discussion on the OTC availability of vascular drugs at a public meeting in Gaithersburg, Md. June 28-29.